Curocell

Curocell

The company is committed to developing innovative technologies to improve the efficacy of cancer treatments and address the limitations of traditional cancer immunotherapy drugs.

HQ location
Daejeon, South Korea
Launch date
Employees
Enterprise value
$121—181m
Company register number
1488800557
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads